The impact on key indicators of reproductive and child health after changes in program modalities in Sierra Leone, 2019.
Albendazole
Sierra Leone
complementary feeding
family planning
vitamin A supplementation
Journal
Health science reports
ISSN: 2398-8835
Titre abrégé: Health Sci Rep
Pays: United States
ID NLM: 101728855
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
21
10
2020
revised:
06
02
2021
accepted:
18
02
2021
entrez:
1
7
2021
pubmed:
2
7
2021
medline:
2
7
2021
Statut:
epublish
Résumé
In 2018, the transition to routine vitamin A supplementation (VAS) was integrated with caregivers' preparation of nutritious complementary food from local produce and confidential counseling and provision of modern contraceptives. In 2019, funding for complementary food ceased and Community Health Workers (CHWs) were trained to track defaulters, while national efforts to improve Health Management Information Systems, supply chains and reduce teenage pregnancies were intensified. We report on key indicators after these changes and in comparison, to those previously published. The same Lot Quality Assurance Sampling methodology was used in both assessments: 19 villages were randomly selected in each of five lots in each of three districts then caregivers of children 6-59 months age randomly selected and interviewed. Coverage of VAS, Albendazole, and Pentavalent 3 before and after these changes was over 80%, 75%, and 80% respectively, equitable by sex, age, caregiver's religion, and educational status. Comparison with 2018 found more lots failed to reach 80% VAS by verbal affirmation (10 vs 2), and coverage in one district (Bo) had dropped (77.5% vs 92.3%). Fewer caregivers were aware that VAS should be taken every 6 months (27% vs 50%), that complementary feeding should start at 6 months (63% vs 77%) or were providing minimal dietary diversity (27% vs 45%). There was an increase in caregivers using modern contraception (45% vs 35%), obtaining information about contraception from a friend (14% vs 9%), while fewer thought country rope/herbs (traditional contraceptives) were "effective" (11% vs 21%) and stockouts of contraceptives at health facilities had dropped (24% vs 55%). Stipends for CHWs cost approximately $750 K vs complementary food: $112 K. Overall coverage for VAS, Albendazole, and Pentavalent remained effective but VAS had dropped significantly in one district. Complementary feeding practices had declined. Awareness, uptake, and contraceptives supply chains had improved.
Sections du résumé
BACKGROUND AND AIMS
OBJECTIVE
In 2018, the transition to routine vitamin A supplementation (VAS) was integrated with caregivers' preparation of nutritious complementary food from local produce and confidential counseling and provision of modern contraceptives. In 2019, funding for complementary food ceased and Community Health Workers (CHWs) were trained to track defaulters, while national efforts to improve Health Management Information Systems, supply chains and reduce teenage pregnancies were intensified. We report on key indicators after these changes and in comparison, to those previously published.
METHODS
METHODS
The same Lot Quality Assurance Sampling methodology was used in both assessments: 19 villages were randomly selected in each of five lots in each of three districts then caregivers of children 6-59 months age randomly selected and interviewed.
RESULTS
RESULTS
Coverage of VAS, Albendazole, and Pentavalent 3 before and after these changes was over 80%, 75%, and 80% respectively, equitable by sex, age, caregiver's religion, and educational status. Comparison with 2018 found more lots failed to reach 80% VAS by verbal affirmation (10 vs 2), and coverage in one district (Bo) had dropped (77.5% vs 92.3%). Fewer caregivers were aware that VAS should be taken every 6 months (27% vs 50%), that complementary feeding should start at 6 months (63% vs 77%) or were providing minimal dietary diversity (27% vs 45%). There was an increase in caregivers using modern contraception (45% vs 35%), obtaining information about contraception from a friend (14% vs 9%), while fewer thought country rope/herbs (traditional contraceptives) were "effective" (11% vs 21%) and stockouts of contraceptives at health facilities had dropped (24% vs 55%). Stipends for CHWs cost approximately $750 K vs complementary food: $112 K.
CONCLUSION
CONCLUSIONS
Overall coverage for VAS, Albendazole, and Pentavalent remained effective but VAS had dropped significantly in one district. Complementary feeding practices had declined. Awareness, uptake, and contraceptives supply chains had improved.
Identifiants
pubmed: 34195385
doi: 10.1002/hsr2.297
pii: HSR2297
pmc: PMC8238388
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e297Informations de copyright
© 2021 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Déclaration de conflit d'intérêts
The authors state that there is no competing interest and the contents are the responsibility of the authors and do not necessarily reflect the views of the Irish Aid, UNICEF, UNFPA or the Canadian Government. Habib I. Kamara affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.
Références
Issues Brief (Alan Guttmacher Inst). 2002 Apr;(2):1-4
pubmed: 12134892
Am J Public Health. 1992 May;82(5):691-4
pubmed: 1566948
Infect Dis Poverty. 2019 Jul 2;8(1):41
pubmed: 31262367
Matern Child Nutr. 2020 Oct;16(4):e13041
pubmed: 32720469
Matern Child Nutr. 2019 Jan;15 Suppl 1:e12738
pubmed: 30748112
Lancet. 2013 Aug 3;382(9890):452-477
pubmed: 23746776
Int J Health Plann Manage. 2019 Apr;34(2):701-713
pubmed: 30680789
Lancet. 2008 Jan 26;371(9609):340-57
pubmed: 18206223
Hum Reprod. 2015 Apr;30(4):973-86
pubmed: 25650409
Eur J Contracept Reprod Health Care. 2017 Oct;22(5):384-390
pubmed: 29087737
Cochrane Database Syst Rev. 2017 Mar 11;3:CD008524
pubmed: 28282701
Lancet. 2008 Feb 9;371(9611):510-26
pubmed: 18206224
Lancet. 2008 Jan 19;371(9608):243-60
pubmed: 18207566
Matern Child Health J. 2015 Sep;19(9):1985-92
pubmed: 25665894
BMC Public Health. 2013;13 Suppl 3:S6
pubmed: 24564713
J Matern Fetal Neonatal Med. 2020 Oct;33(20):3501-3508
pubmed: 30696314
Glob Health Sci Pract. 2013 Jun 26;1(2):172-9
pubmed: 25276530
Int Health. 2015 Jan;7(1):26-31
pubmed: 25316706
Stud Fam Plann. 2014 Sep;45(3):301-14
pubmed: 25207494